Mercy House Teen Challenge v. Purdue Pharma L.P. et al
| Mercy House Teen Challenge |
| Janssen Pharmaceutica Inc., Purdue Pharma L.P., Mallinckrodt LLC, McKesson Corporation, Mallinckrodt PLC, Watson Laboratories Inc., Allergan PLC, Teva Pharmaceuticals USA, Inc., Janssen Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Actavis LLC, Cephalon Inc., Actavis Pharma, Inc., Purdue Frederick Company, Inc., Cardinal Health Inc., Endo Health Solutions Inc., Johnson & Johnson, Watson Pharmaceuticals, Inc., AmerisourceBergen Drug Corporation, Noramco Inc, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd. and Purdue Pharma Inc. |
| 1:2018op46070 |
| September 18, 2018 |
| US District Court for the Northern District of Ohio |
| Dan Aaron Polster (MDL 2804) |
| Racketeer/Corrupt Organization |
| 18 U.S.C. ยง 1961 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 1, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 Waiver of Service Returned Executed by Mercy House Teen Challenge. Actavis LLC waiver sent on 10/11/2018, answer due 12/10/2018; Actavis Pharma, Inc. waiver sent on 10/11/2018, answer due 12/10/2018; Cephalon Inc. waiver sent on 10/11/2018, answer due 12/10/2018; Teva Pharmaceuticals USA, Inc. waiver sent on 10/11/2018, answer due 12/10/2018; Watson Laboratories Inc. waiver sent on 10/11/2018, answer due 12/10/2018 filed on behalf of Mercy House Teen Challenge (Eaves, John) |
| Filing 8 CASE TRANSFERRED IN from District of Mississippi Southern. Case number 3:18-cv-00584. Original file, certified copy of transfer order and docket sheet received. |
| Filing 7 CERTIFIED COPY OF CONDITIONAL TRANSFER ORDER: transferring this case to the Northern District of Ohio. Signed on 09/17/18 (KNS) [Transferred from mssd on 9/18/2018.] |
| Filing 6 COPY OF CONDITIONAL TRANSFER ORDER Signed on 09/17/18. (KNS) [Transferred from mssd on 9/18/2018.] |
| Filing 5 RICO Statement by Mercy House Teen Challenge (Eaves, John) [Transferred from mssd on 9/18/2018.] |
| Filing 4 ***ERROR***DISREGARD THIS ENTRY***RICO Statement by Mercy House Teen Challenge (Eaves, John) Modified on 8/24/2018 (KNS). [Transferred from mssd on 9/18/2018.] |
| Filing 3 RICO Notice by USDC, Clerk. (KNS) [Transferred from mssd on 9/18/2018.] |
| Filing 2 Letter from USDC, Clerk to MDL Clerk with copies of docket sheet and complaint. (KNS) [Transferred from mssd on 9/18/2018.] |
| DOCKET ANNOTATION as to #4 : There is an error in this entry, and it should be disregarded. It has been correctly refiled as Doc. #5 . (KNS) [Transferred from mssd on 9/18/2018.] |
| Filing 1 COMPLAINT against Actavis LLC, Actavis Pharma, Inc., Allergan PLC, Amerisourcebergen Drug Corporation, Cardinal Health, Inc., Cephalon, Inc., Endo Health Solutions Inc., Endo Pharmaceuticals, Inc., Janssen Pharmaceutica Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt LLC, Mallinckrodt PLC, McKesson Corporation, Noramco, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc., Purdue Pharma L.P., Purdue Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., The Purdue Frederick Company, Inc., Watson Laboratories, Inc., Watson Pharmaceuticals, Inc. ( Filing fee $ 400 receipt number 0538-3792434), filed by Mercy House Teen Challenge. (Attachments: #1 Civil Cover Sheet)(KNS) [Transferred from mssd on 9/18/2018.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Ohio Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
